Skip to content
AnalystLens

Accenture plc 8-K Report, Executive Changes (May 12, 2014)

Reports
Leadership Changes·Exhibits & Filings
Filing Date
Filed May 12, 2014
Period End
May 9, 2014
Security
ACN
In the record · 2016–202610-K1010-Q328-K98

ACN filed 10 annual reports (10-K), 32 quarterly reports (10-Q) and 98 current reports (8-K) between 2016 and 2026.

  1. Leadership change8-K · Jul ’19Jul ’19
  2. Leadership change8-K · Jun ’21Jun ’21
  3. FY2025 annual report10-K · Oct ’25Oct ’25

Summary

Summary of the 8-K filed May 12, 2014. Cited figures are marked; the original filing is the authoritative source.

This Accenture plc (ACN) 8-K filing from May 12, 2014, primarily announces the appointment of two new independent directors to its Board of Directors: Paula A.

Price and Frank K. Tang. Both appointments were recommended by the Nominating & Governance Committee and are effective as of May 9, 2014.

Ms. Price brings extensive financial leadership experience, having served as CFO of Ahold USA and as controller and chief accounting officer at CVS Caremark, with prior roles at JPMorgan Chase. Mr. Tang offers significant expertise in private equity and investment banking, particularly within China, through his roles at FountainVest Partners and Temasek Holdings, as well as an 11-year tenure at Goldman Sachs. These appointments are strategic additions to the Board, bringing diverse and valuable skill sets in finance, accounting, and international investment.

Ms. Price will enhance the Audit Committee's expertise, while Mr. Tang's background will benefit the Finance Committee. Both directors will receive standard board and committee compensation, along with restricted share units, and will be subject to shareholder re-appointment at the 2015 annual general meeting.

Key Highlights

  1. Accenture appointed Paula A. Price and Frank K. Tang as new directors to its Board of Directors on May 9, 2014.
  2. Paula A. Price has significant financial and accounting expertise, with prior executive roles at Ahold USA and CVS Caremark.
  3. Frank K. Tang brings substantial experience in private equity and investment banking, particularly in China, from FountainVest Partners, Temasek Holdings, and Goldman Sachs.
  4. Ms. Price has been appointed to the Board's Audit Committee.
  5. Mr. Tang has been appointed to the Board's Finance Committee.
  6. Both new directors will receive standard compensation for board and committee service, along with a new director grant of restricted share units valued at $185,000.
  7. New directors will serve until the Company's 2015 annual general meeting, when they will be subject to shareholder re-appointment.

Frequently Asked Questions

  1. Why are Paula A. Price and Frank K. Tang being appointed to the Board?

    Paula A. Price and Frank K. Tang are being appointed to the Board of Directors to bring valuable financial, accounting, and international investment expertise to Accenture. Ms. Price's extensive background in finance and accounting will strengthen the Audit Committee, while Mr. Tang's experience in private equity and investment banking, particularly in Asia, will be beneficial to the Finance Committee and the company's global strategy.

  2. What will be the compensation for the new directors?

    The new directors will receive a pro rata portion of the standard compensation for board service ($90,000 per annum) and committee service ($7,500 per annum for the Audit Committee and $5,000 per annum for the Finance Committee), based on the remaining days in the current director compensation year. Additionally, they will each receive a restricted share unit grant valued at $185,000.

  3. What is the tenure of the new directors on the Board?

    Ms. Price and Mr. Tang will each serve on the Board until the Company's 2015 annual general meeting of shareholders. At that meeting, they will be subject to re-appointment by a vote of the Company's shareholders.

  4. Does this filing indicate any changes in Accenture's financial performance or outlook?

    No, this 8-K filing is solely related to the appointment of new directors to the Board. It does not contain any information regarding Accenture's financial performance, results, or future outlook. This type of announcement is typically related to corporate governance rather than operational or financial updates.